Dual Immunotherapy and Liver Perfusion Delays Progression in Uveal Melanoma
(MedPage Today) -- Adding the dual checkpoint inhibitor regimen of ipilimumab (Yervoy) and nivolumab (Opdivo) to percutaneous hepatic perfusion significantly ...
(MedPage Today) -- Adding the dual checkpoint inhibitor regimen of ipilimumab (Yervoy) and nivolumab (Opdivo) to percutaneous hepatic perfusion significantly ...
Cancer immunotherapy has been a game-changer, but many tumors still find ways to slip past the immune system. New research ...
Scientists have discovered that T cell receptors activate through a hidden spring-like motion that had never been seen before. This ...
Adding immunotherapy to new KRAS inhibitors boosted responses in preclinical models, setting the stage for future trials of the combination ...
Researchers have discovered a novel immunotherapy combination, targeting checkpoints in both T cells and myeloid suppressor cells, that successfully reprogrammed ...
© 2025 PickByDoc. All rights reserved. PickByDoc is a medical news & health awareness platform.